☆ 4.5 Article

Neoadjuvant chemotherapy enhances tumor-specific T cell immunity in patients with HPV-associated oropharyngeal cancer

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer

Cem Sievers et al.

Summary: Neoadjuvant immunotherapies (NITs) show clinical benefits in various cancers and understanding the molecular mechanisms behind the response to NIT can improve treatment strategies. This study reveals that exhausted tumor-infiltrating CD8+ T cells respond to concurrent TGF-0 and PD-L1 blockade, leading to increased circulating Tex cells and reduced CD103 expression. TGF-0 plays a role in tissue retention and impaired systemic immunity, and transcriptional changes in T cell receptor signaling and glutamine metabolism affect the response to NIT.

CANCER CELL (2023)

添加到收藏夹

Article Oncology

Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)

Robert L. Ferris et al.

Summary: This study aimed to investigate the efficacy and safety of primary transoral surgery (TOS) and reduced postoperative radiation therapy (RT) in intermediate-risk patients with human papillomavirus-associated oropharynx cancer (HPV+ OPC). The results showed that TOS and reduced RT achieved favorable oncologic outcomes and functional outcomes in intermediate-risk HPV+ OPC patients.

JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Otorhinolaryngology

Swallowing Function Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Carcinoma: A 2-Year Follow-up

Esther Lee et al.

Summary: The study evaluated the 2-year follow-up swallowing function in patients with HPV+ OPSCC who completed NAC+S treatment, showing satisfactory long-term swallowing outcomes. Patients who underwent unilateral neck dissection were significantly associated with higher MDADI scores in this study cohort.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer

Jason M. Redman et al.

Summary: Neoadjuvant immunotherapy with dual PD-L1 and TGF-beta blockade can safely enhance tumor antigen-specific immunity and improve survival rate in patients with HPV-unrelated HNSCC. Myeloid cell infiltration in the tumor microenvironment may play a crucial role in enhancing antitumor immune response.

JOURNAL OF CLINICAL INVESTIGATION (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-beta blockade in HPV-unrelated head and neck cancer

Jason M. Redman et al.

Summary: This study demonstrates that dual PD-L1 and TGF-β blockade can safely enhance tumor antigen-specific immunity in patients with HPV-unrelated head and neck squamous cell carcinoma. Neoadjuvant immunotherapy has the potential to induce polyclonal neoadjuvant-specific T cell responses in tumors.

JOURNAL OF CLINICAL INVESTIGATION (2022)

添加到收藏夹

Review Medicine, Research & Experimental

Neutrophil dynamics in the tumor microenvironment

Amanda J. McFarlane et al.

Summary: The tumor microenvironment significantly influences the behavior of immune cells, including both recruited and tissue-resident cells. Recent technological advances have allowed for a better understanding of the true roles of neutrophils in the tumor microenvironment, potentially leading to more effective targeting strategies for these immune cells in clinical settings.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Review Oncology

From Immunogenic Cell Death to Immunogenic Modulation: Select Chemotherapy Regimens Induce a Spectrum of Immune-Enhancing Activities in the Tumor Microenvironment

Kellsye P. Fabian et al.

Summary: Cancer treatment has entered the era of immunotherapy with the importance of rational combination strategies becoming clear. Chemotherapy can induce immunogenic cell stress, promoting immune response. Treatment strategies should be designed to take advantage of these effects.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Otorhinolaryngology

Pathologic response to neoadjuvant chemotherapy in HPV-associated oropharynx cancer

Nader Sadeghi et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)

添加到收藏夹

Article Otorhinolaryngology

Neoadjuvant chemotherapy followed by surgery for HPV-associated locoregionally advanced oropharynx cancer

Nader Sadeghi et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)

添加到收藏夹

Article Immunology

Profiling HPV-16-specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patients

Kunal H. Bhatt et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

添加到收藏夹

Article Oncology

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial

Jonathan D. Schoenfeld et al.

JAMA ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer

So-Jin Park et al.

ORAL ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Phase 2 Trial of Neoadjuvant Chemotherapy and Transoral Endoscopic Surgery With Risk-Adapted Adjuvant Therapy for Squamous Cell Carcinoma of the Head and Neck

Jared M. Weiss et al.

CANCER (2018)

添加到收藏夹

Article Medicine, General & Internal

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

P. M. Forde et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Otorhinolaryngology

Neoadjuvant chemotherapy and transoral surgery as a definitive treatment for oropharyngeal cancer: A feasible novel approach

Nader Sadeghi et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)

添加到收藏夹

Article Oncology

Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death

James W. Hodge et al.

INTERNATIONAL JOURNAL OF CANCER (2013)

添加到收藏夹

Article Oncology

Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy

Johannes A. Langendijk et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

添加到收藏夹

Article Oncology

Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis

Mitchell Machtay et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

添加到收藏夹

Article Hematology

Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application

MS von Bergwelt-Baildon et al.

BLOOD (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.